Browse by category

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

COMBINE trial: Glucose clamp technique as part of a new type 2 diabetes research trial

8 hours ago

Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity

8 hours ago

More than half of US adults could benefit from GLP-1 medications

9 hours ago

Weekly Digest